Abstract
A hybrid pharmacophore approach was used to design and synthesize a series of coumarin derivatives bearing 2-methylbiphenyl moiety, which were evaluated for their in vitro anticancer activities against four cancer cell lines(MCF-7, A549, H460 and HT29) and PD-1/PD-L1 inhibitory activities. Moreover, several compounds with excellent anticancer activities were selected to evaluate the cytotoxicities against one normal cell line(HEK-293). The most promising compound 11o showed the best anticancer activities against the four tested cancer cell lines with the IC50 values of 6.45, 8.65, 6,57 and 8.13 μmol/L, respectively, and displayed weak cytotoxicity on the normal cell(HEK-293). Furthermore, screening of PD-1/PD-L1inhibitory activity revealed that compound 11o could effectively inhibit the binding of PD-1/PD-L1, and the binding interactions of compound 11o with PD-L1 protein were explored by molecular docking. All above evidences showed that compound 11o might be worthy of further study as a valuable leading compound for the treatment of cancer.
Similar content being viewed by others
References
Kim S. K., Kalimuthu S., Handbook of Anticancer Drugs from Marine Origin, Springer, Cham, 2015
Hu Y., Shen Y., Wu X., Tu X., Wang G. X., Eur. J. Med. Chem., 2018, 143, 958
Weigt S., Huebler N., Strecker R., Braunbeck T., Broschard T. H., Reprod. Toxicol., 2012, 33(2), 133
Pérez-Cruz K., Moncada-Basualto M., Morales-Valenzuela J., Barriga-González G., Navarrete-Encina P., Núñez-Vergara L., Squella J. A., Olea-Azar C., Arab. J. Chem., 2018, 11(4), 525
Keri R. S., Sasidhar B. S., Nagaraja B. M., Santos M. A., Eur. J. Med. Chem., 2015, 100, 257
Koparde S., Hosamani K. M., Kulkarni V., Joshi S. D., Chem. Dat. Collect., 2018, 15/16, 197
Ghanei-Nasab S., Khoobi M., Hadizadeh F., Marjani A., Moradi A., Nadri H., Emami S., Foroumadi A., Shafiee A., Eur. J. Med. Chem., 2016, 121, 40
Shen Y. F., Liu L., Feng C. Z., Hu Y., Chen C., Wang G. X., Zhu B., Fish Shellfish Immunol., 2018, 81, 57
Escudero G. E., Laino C. H., Echeverría G. A., Piro O. E., Martini N., Rodríguez A. N., Martínez M. J. J., López T. L. L., Ferrer E. G., Williams P. A. M., Chem. Biol. Interact., 2016, 249, 46
Woo L. W. L., Ganeshapillai D., Thomas M. P., Sutcliffe O. B., Malini B., Mahon M. F., Purohit A., Potter B. V. L., ChemMedChem, 2011, 6(11), 2019
Stefanachi A., Favia A. D., Nicolotti O., Leonetti F., Pisani L., Catto M., Zimmer C., Hartmann R. W., Carotti A., J. Med. Chem., 2011, 54(6), 1613
Reddy N. S., Gumireddy K., Mallireddigari M. R., Cosenza S. C., Venkatapuram P., Bell S. C., Reddy E. P., Reddy M. V. R., Biorg. Med. Chem., 2005, 13(9), 3141
Kusuma B. R., Khandelwal A., Gu W., Brown D., Liu W., Vielhauer G., Holzbeierlein J., Blagg B. S. J., Biorg. Med. Chem., 2014, 22(4), 1441
Wu X. Q., Huang C., Jia Y. M., Song B. A., Li J., Liu X. H., Eur. J. Med. Chem., 2014, 74, 717
Guzik K., Zak K. M., Grudnik P., Magiera K., Musielak B., Törner R., Skalniak L., Dömling A., Dubin G., Holak T. A., J. Med. Chem., 2017, 60(13), 5857
Zak K. M., Grudnik P., Guzik K., Zieba B. J., Musielak B., Dömling A., Dubin G., Holak T. A., Oncotarget, 2016, 7(21), 30323
Chupak L. S., Zhang X. F., Compounds Useful as Immunomodulators, WO2015034820, 2015
Pan S., Wu X., Jiang J., Gao W., Wan Y., Cheng D., Han D., Liu J., Englund N. P., Wang Y., Peukert S., Miller-Moslin K., Yuan J., Guo R., Matsumoto M., Vattay A., Jiang Y., Tsao J., Sun F., Pferdekamper A. C., Dodd S., Tuntland T., Maniara W., Kelleher J. F., Yao Y. M., Warmuth M., Williams J., Dorsch M., ACS Medicinal Chemistry Letters, 2010, 1(3), 130
Tauchi T., Arthrit. Res. Ther., 2012, 14(Suppl. 1), O43
Fendrich V., Wiese D., Waldmann J., Lauth M., Heverhagen A. E., Rehm J., Bartsch D. K., Ann. Surg., 2011, 254(5), 818
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supported by the National Natural Science Foundation of China(No.81602970), the Promotion Program for Young and Middle- aged Teacher in Science and Technology Research of Huaqiao University, China(No.ZQN-PY519), the Science and Technology Project of Quanzhou City, China(No.2018C074R) and the Subsidized Project for Postgraduates’ Innovative Fund in Scientific Research of Huaqiao University, China.
Rights and permissions
About this article
Cite this article
Ma, J., Huang, K., Ni, X. et al. Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methylbiphenyl Moiety. Chem. Res. Chin. Univ. 35, 410–417 (2019). https://doi.org/10.1007/s40242-019-8310-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-019-8310-7